# Huaier Granule for Prevention of Recurrence and Metastasis of Stage II and III Non-small Cell Lung Cancer (NSCLC)

> **NCT03198117** · NA · TERMINATED · sponsor: **Qidong Gaitianli Medicines Co., Ltd** · enrollment: 6 (actual)

## Conditions studied

- Non-small Cell Lung Cancer

## Interventions

- **DRUG:** Huaier Granule
- **OTHER:** placebo

## Key facts

- **NCT ID:** NCT03198117
- **Lead sponsor:** Qidong Gaitianli Medicines Co., Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2017-04-25
- **Primary completion:** 2017-11-23
- **Final completion:** 2017-11-23
- **Target enrollment:** 6 (ACTUAL)
- **Why stopped:** Difficulty in patient recruitment
- **Last updated:** 2020-03-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03198117

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03198117, "Huaier Granule for Prevention of Recurrence and Metastasis of Stage II and III Non-small Cell Lung Cancer (NSCLC)". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03198117. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*